[1]
“Cost-effectiveness evaluations of spinal neuromodulation with ziconotide continuous infusion in cancer pain in a real clinical practice”, FE, vol. 12, no. 2, pp. 87–94, Jun. 2011, doi: 10.7175/fe.v12i2.74.